|
Sign In to gain access to subscriptions and/or personal tools.
|
Total Parenteral Nutrition-Related Cholestasis in Infants
R.L. Bell, PH.D.
University of Texas School of Public Health
G.D. Ferry, M.D.
Baylor College of Medicine, Houston, Texas
E.O. Smith, PH.D.
Baylor College of Medicine, Houston, Texas
R.J. Shulman, M.D.
Baylor College of Medicine, Houston, Texas
B.L. Christensen, PH.D.
University of Texas School of Public Health
D.R. Labarthe, PH.D.
University of Texas School of Public Health
C.A. Wills, M.S.
Baylor College of Medicine, Houston, Texas
An epidemiological study was conducted to estimate the proportion of infants on total parenteral nutrition (TPN) who developed cholestasis and to identify risk factors associated with the development of this disease. Data were abstracted from medical records of 624 infants 30 days of age who were treated with TPN. A case of TPN-related cholestasis was defined as an infant whose serum level of direct bilirubin was 1.5 mg/dl subsequent to initiation of TPN. Risk factors were assessed using multiple logistic regression analysis. Forty-six of 624 infants in the cohort (7.4%) were classified as having TPN-related cholestasis. The multivariable analysis indicated that cholestasis was associated with intracranial hemorrhage, patent ductus arteriosus, sepsis and gastrointestinal conditions that require surgery. Two distinct processes appear to have occurred: (1) in infants who experienced patent ductus arteriosus or intracranial hemorrhage (conditions associated with hypoxia) where TPN may be the necessary trigger for the development of cholestasis, and (2) in infants with gastrointestinal conditions requiring surgery or sepsis, where cholestasis may develop with or without parenteral infusions. (Journal of Parenteral and Enteral Nutrition 10:356-359, 1986)
Journal of Parenteral and Enteral Nutrition, Vol. 10, No. 4,
356-359 (1986)
DOI: 10.1177/0148607186010004356

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. A Prescott Jr and I. F Btaiche
Sincalide in Patients with Parenteral Nutrition-Associated Gallbladder Disease
Ann. Pharmacother.,
November 1, 2004;
38(11):
1942 - 1945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. I. J. Albers, D.-A. H. de Gast-Bakker, N. A. M. van Dam, G. C. Madern, and D. Tibboel
Male Sex Predisposes the Newborn Surgical Patient to Parenteral Nutrition-Associated Cholestasis and to Sepsis
Arch Surg,
July 1, 2002;
137(7):
789 - 793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Teitelbaum, T. Han-Markey, R. A. Drongowski, A. G. Coran, B. Bayar, J. D. Geiger, N. Uitvlugt, and M. A. Schork
Use of Cholecystokinin to Prevent the Development of Parenteral Nutrition-Associated Cholestasis
JPEN J Parenter Enteral Nutr,
March 1, 1997;
21(2):
100 - 103.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Zaman, Y. K. Tam, L. D. Jewel, and R. T. Coutts
Effects of Cholestyramine and Parenteral Nutrition on Hepatic Metabolism of Lidocaine: A Study Using Isolated Rat Liver Perfusion
JPEN J Parenter Enteral Nutr,
September 1, 1996;
20(5):
349 - 356.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Toce and W. J. Keenan
Lipid Intolerance in Newborns Is Associated With Hepatic Dysfunction but Not Infection
Arch Pediatr Adolesc Med,
November 1, 1995;
149(11):
1249 - 1253.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Spurr, L. J. Grylack, and N. R. Mehta
Hyperalimentation-Associated Neonatal Cholestasis: Effect of Oral Gentamicin
JPEN J Parenter Enteral Nutr,
November 1, 1989;
13(6):
633 - 636.
[Abstract]
[PDF]
|
 |
|
|
|